{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:32:25Z","timestamp":1787808745345,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jaip.2022.09.034","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T03:14:28Z","timestamp":1664766868000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Diagnosis and Assessment of the Asthmas"],"prefix":"10.1016","volume":"11","author":[{"given":"Ian D.","family":"Pavord","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lemi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.09.034_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrd3534","article-title":"A\u00a0call to reform the taxonomy of human disease","volume":"10","author":"Kola","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaip.2022.09.034_bib2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(58)91385-0","article-title":"Treatment of chronic asthma with prednisolone; significance of eosinophils in the sputum","volume":"2","author":"Brown","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.09.034_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1753465815581279","article-title":"Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma","volume":"9","author":"Hilvering","year":"2015","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.jaip.2022.09.034_bib4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nrd1524","article-title":"New drugs for asthma","volume":"3","author":"Barnes","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaip.2022.09.034_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.09.034_bib6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/thx.52.6.498","article-title":"The use of induced sputum to investigate airway inflammation","volume":"52","author":"Pavord","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2022.09.034_bib7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(08)61421-X","article-title":"Inflammometry to assess airway diseases","volume":"372","author":"Pavord","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.09.034_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jaci.2014.12.1871","article-title":"Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care","volume":"135","author":"Fajt","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.034_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma\u2014present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2022.09.034_bib10","first-page":"13","article-title":"The definition of asthma: general introduction","volume":"38","author":"Scadding","year":"1971","journal-title":"Ciba Found Study Group"},{"key":"10.1016\/j.jaip.2022.09.034_bib11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/thx.40.12.887","article-title":"Henry Hyde Salter (1823-71): a biographical sketch","volume":"40","author":"Sakula","year":"1985","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2022.09.034_bib13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(17)31448-4","article-title":"Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993-2012)","volume":"390","author":"Ebmeier","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.09.034_bib14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(89)92505-1","article-title":"Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study","volume":"1","author":"Crane","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.09.034_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.09.034_bib16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1378\/chest.121.4.1051","article-title":"A\u00a0comparison of the validity of different diagnostic tests in adults with asthma","volume":"121","author":"Hunter","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2022.09.034_bib17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2022.09.034_bib18","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1164\/rccm.201910-1934CI","article-title":"Optimal asthma control: time for a new target","volume":"201","author":"Beasley","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2022.09.034_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2022.09.034_bib20","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","article-title":"Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group","volume":"337","author":"Pauwels","year":"1997","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.jaip.2022.09.034_bib21","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.09.034_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S2213-2600(21)00021-7","article-title":"Balancing the needs of the many and the few: where next for adult asthma guidelines?","volume":"9","author":"Shaw","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2022.09.034_bib23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jaip.2020.08.039","article-title":"Clinical development of mepolizumab for the treatment of severe eosinophilic asthma: on the path to personalized medicine","volume":"9","author":"Pavord","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.034_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2022.09.034_bib25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01105-2021","article-title":"A\u00a0new piece in the puzzle: the eosinophil and the development of COPD","volume":"58","author":"Petousi","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.09.034_bib26","doi-asserted-by":"crossref","first-page":"00570","DOI":"10.1183\/23120541.00570-2021","article-title":"Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)","volume":"8","author":"Couillard","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2022.09.034_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(20)30053-9","article-title":"Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial","volume":"8","author":"Pavord","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2022.09.034_bib28","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(11)60971-9","article-title":"Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial","volume":"378","author":"Powell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.09.034_bib29","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thoraxjnl-2018-211540","article-title":"Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis","volume":"73","author":"Petsky","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2022.09.034_bib30","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S2213-2600(18)30386-2","article-title":"Do we really need a new classification of airway diseases?","volume":"6","author":"Agusti","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2022.09.034_bib31","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04173-2020","article-title":"European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5\u201316 years","volume":"58","author":"Gaillard","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.09.034_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2016.19627","article-title":"Reevaluation of diagnosis in adults with physician-diagnosed asthma","volume":"317","author":"Aaron","year":"2017","journal-title":"JAMA"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822009722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822009722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:38:29Z","timestamp":1761975509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822009722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213219822009722"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.09.034","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Assessment of the Asthmas","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}